Study on chronic kidney disease in American Indian populations

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on understanding chronic kidney disease (CKD) and cardiovascular disease (CVD) among American Indians in the Southwestern United States. It aims to identify unique risk factors for CKD progression and compare event rates between American Indians and other populations. Participants will undergo a series of assessments including medical history, blood tests, and questionnaires to gather comprehensive health data. The study will also establish a specimen bank for future research on biomarkers related to CKD progression.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Glomerular Filtration Rate (GFR): eGFR of =\>61\<80 and microalbuminuria \> 30 or eGRF of =\<60 (no microalbuminuria required).

Exclusion Criteria:

1. Unable or unwilling to provide informed consent
2. life expectancy \<3 years;
3. institutionalized subjects;
4. End stage renal disease or renal transplant;
5. renal cancer;
6. myeloma;
7. immunosuppression;
8. Polycystic kidney disease;
9. participation in any clinical trial,
10. current pregnancy
11. current incarceration.
12. Appears unlikely or unable to participate in the required study procedures as assessed by the investigator, study coordinator or designee.

Where it's running

• First Nations Community Health Source
  Albuquerque, New Mexico, United States Recruiting
• Zuni Health Initiative Center
  Black Rock, New Mexico, United States Recruiting
• NIDDK-Phoenix Epidemiology and Clinical Research
  Phoenix, Arizona, United States Not yet recruiting

Study contacts

• Principal investigator: Mark L Unruh, MD — University of New Mexico
• Study coordinator: Mark L Unruh, MD
• Email: MLUnruh@salud.unm.edu
• Phone: 505-272-8300

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Streamlined renal denervation with Spyral for uncontrolled high blood pressure

  This trial will test whether a shorter, simpler renal denervation procedure using the Symplicity Spyral system can lower blood pressure in adults with uncontrolled hypertension.

  Recruiting at 20 sites Medtronic Vascular · Melbourne and 20 other locations · NCT07115953

• Gemini multi-organ denervation for uncontrolled high blood pressure

  The Gemini System is being tested to see if multi-organ denervation is safe and can lower blood pressure in adults with uncontrolled hypertension, with or without high cardiovascular risk.

  Recruiting at 18 sites Medtronic Vascular · Stanford, California and 17 other locations · NCT06907147

• Research on health inequality and genetic disparity in cardiovascular diseases

  This study is trying to understand how health differences and genetics affect heart diseases in people from various ethnic backgrounds in the UK to help improve treatments for everyone.

  Recruiting Future Genetics Limited · Wolverhampton, West Midlands · NCT03987633

• TRIFORMIS RESILIA heart valve real-world results in tricuspid disease

  A real-world, observational study to see how the Edwards TRIFORMIS RESILIA tricuspid heart valve performs in adults needing tricuspid valve replacement.

  Recruiting Edwards Lifesciences · Carmel, Indiana · NCT07684313

• Home-based cardiovascular health screening for people turning 50, 55, 60, 65, 70 or 75 in Uppsala

  This trial tests whether giving people a home blood pressure monitor, a dried blood spot kit, and a questionnaire can find more cardiovascular risk factors than usual care.

  Recruiting Uppsala University · Uppsala · NCT07614659

• Women-Focused Education in Cardiac Rehab

  This pilot test checks if a women-focused education program added to standard cardiac rehab is feasible and helps women improve heart-health knowledge, quality of life, and healthy behaviors.

  Recruiting University Health Network, Toronto · Barrie, Ontario and 2 other locations · NCT07550036

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.